![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo
Yaohua Wei, Yinping Sun, Jingjing Wei, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 521-529
Open Access | Times Cited: 46
Yaohua Wei, Yinping Sun, Jingjing Wei, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 521-529
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 84
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 84
Current understanding of passive and active targeting nanomedicines to enhance tumor accumulation
Zhoujiang Chen, Ranjith Kumar Kankala, Lianlin Long, et al.
Coordination Chemistry Reviews (2023) Vol. 481, pp. 215051-215051
Closed Access | Times Cited: 50
Zhoujiang Chen, Ranjith Kumar Kankala, Lianlin Long, et al.
Coordination Chemistry Reviews (2023) Vol. 481, pp. 215051-215051
Closed Access | Times Cited: 50
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Polysaccharide-based nanocarriers for efficient transvascular drug delivery
Min Zhang, He Ma, Xijie Wang, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 167-187
Closed Access | Times Cited: 42
Min Zhang, He Ma, Xijie Wang, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 167-187
Closed Access | Times Cited: 42
Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 47
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 47
Non-invasive PTEN mRNA brain delivery effectively mitigates growth of orthotopic glioblastoma
Yanjie Liu, Dongya Zhang, Yang An, et al.
Nano Today (2023) Vol. 49, pp. 101790-101790
Closed Access | Times Cited: 32
Yanjie Liu, Dongya Zhang, Yang An, et al.
Nano Today (2023) Vol. 49, pp. 101790-101790
Closed Access | Times Cited: 32
Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy
Jianping Chen, Jiahao Pan, Sijia Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 45
Open Access | Times Cited: 26
Jianping Chen, Jiahao Pan, Sijia Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 45
Open Access | Times Cited: 26
PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting
Qiuli Du, Yan Liu, Mengyu Fan, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 85-94
Closed Access | Times Cited: 6
Qiuli Du, Yan Liu, Mengyu Fan, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 85-94
Closed Access | Times Cited: 6
Targeted Modulation of the Meningeal Lymphatic Reverse Pathway for Immunotherapy of Breast Cancer Brain Metastases
Yanfeng Dai, Xiang Yu, Yifan Zhao, et al.
ACS Nano (2025)
Closed Access
Yanfeng Dai, Xiang Yu, Yifan Zhao, et al.
ACS Nano (2025)
Closed Access
Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer’s disease
Ya Wei, Xue Xia, Xiaorong Wang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Ya Wei, Xue Xia, Xiaorong Wang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice
Daozhou Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Daozhou Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer
Solmaz Mojarad-Jabali, Somayeh Mahdinloo, Masoud Farshbaf, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 6, pp. 685-705
Closed Access | Times Cited: 30
Solmaz Mojarad-Jabali, Somayeh Mahdinloo, Masoud Farshbaf, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 6, pp. 685-705
Closed Access | Times Cited: 30
A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy
Yongchao Chu, Yifan Luo, Boyu Su, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 1, pp. 298-314
Open Access | Times Cited: 27
Yongchao Chu, Yifan Luo, Boyu Su, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 1, pp. 298-314
Open Access | Times Cited: 27
New Drug Delivery Systems Developed for Brain Targeting
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 25
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 25
Harnessing Protein Corona for Biomimetic Nanomedicine Design
Zhidong Chen, Xu Chen, Juyang Huang, et al.
Biomimetics (2022) Vol. 7, Iss. 3, pp. 126-126
Open Access | Times Cited: 24
Zhidong Chen, Xu Chen, Juyang Huang, et al.
Biomimetics (2022) Vol. 7, Iss. 3, pp. 126-126
Open Access | Times Cited: 24
Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategies
Yogita Chhichholiya, Malayil Ruthuparna, Harini Velagaleti, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 5, pp. 1218-1241
Closed Access | Times Cited: 13
Yogita Chhichholiya, Malayil Ruthuparna, Harini Velagaleti, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 5, pp. 1218-1241
Closed Access | Times Cited: 13
Nucleic acid-based therapy for brain cancer: Challenges and strategies
Zixia Zhang, João Conniot, Joana Amorim, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 80-92
Open Access | Times Cited: 19
Zixia Zhang, João Conniot, Joana Amorim, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 80-92
Open Access | Times Cited: 19
Inflammatory responsive neutrophil-like membrane-based drug delivery system for post-surgical glioblastoma therapy
Huajian Chen, Jingsen Ji, Li Zhang, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 479-488
Closed Access | Times Cited: 10
Huajian Chen, Jingsen Ji, Li Zhang, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 479-488
Closed Access | Times Cited: 10
Extracellular vesicles: powerful candidates in nano-drug delivery systems
Xiaofei Liu, Yinfang Cao, Shuming Wang, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 2, pp. 295-311
Closed Access | Times Cited: 10
Xiaofei Liu, Yinfang Cao, Shuming Wang, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 2, pp. 295-311
Closed Access | Times Cited: 10
Protein adsorption onto nanomaterials engineered for theranostic applications
Karin Nienhaus, Yumeng Xue, Li Shang, et al.
Nanotechnology (2022) Vol. 33, Iss. 26, pp. 262001-262001
Closed Access | Times Cited: 15
Karin Nienhaus, Yumeng Xue, Li Shang, et al.
Nanotechnology (2022) Vol. 33, Iss. 26, pp. 262001-262001
Closed Access | Times Cited: 15
Small extracellular vesicles in breast cancer brain metastasis and the prospect of clinical application
Tingli Luo, Yue Kang, Yushi Liu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
Tingli Luo, Yue Kang, Yushi Liu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
Effect of the size of nucleic acid delivery systems on their fate in cancer treatment
Mengyun Ye, Junni Gong, Wang Chen, et al.
(2024), pp. 38-49
Open Access | Times Cited: 2
Mengyun Ye, Junni Gong, Wang Chen, et al.
(2024), pp. 38-49
Open Access | Times Cited: 2
Stimuli-Responsive Polymersomes: Reshaping the Immunosuppressive Tumor Microenvironment
Yaohua Wei, Xiao Weng, Yayun Wang, et al.
Biomacromolecules (2024) Vol. 25, Iss. 8, pp. 4663-4676
Closed Access | Times Cited: 2
Yaohua Wei, Xiao Weng, Yayun Wang, et al.
Biomacromolecules (2024) Vol. 25, Iss. 8, pp. 4663-4676
Closed Access | Times Cited: 2
A D-peptide ligand of neuropeptide Y receptor Y1 serves as nanocarrier traversing of the blood brain barrier and targets glioma
Yanying Li, Yuanbo Pan, Yinjie Wang, et al.
Nano Today (2022) Vol. 44, pp. 101465-101465
Closed Access | Times Cited: 14
Yanying Li, Yuanbo Pan, Yinjie Wang, et al.
Nano Today (2022) Vol. 44, pp. 101465-101465
Closed Access | Times Cited: 14
Ursolic acid nanoparticles for glioblastoma therapy
Yong Li, Linyao Zhao, Qingyu Zhao, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 50, pp. 102684-102684
Closed Access | Times Cited: 7
Yong Li, Linyao Zhao, Qingyu Zhao, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 50, pp. 102684-102684
Closed Access | Times Cited: 7